On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Haya Ascher‐Svanum

ResearcherPublications, citations & collaboration network

Haya Ascher‐Svanum is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Haya Ascher‐Svanum have?

ScholarIQindexed works

Haya Ascher‐Svanum has 233 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Haya Ascher‐Svanum have?

ScholarIQcitation count

Haya Ascher‐Svanum has 5,631 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Haya Ascher‐Svanum?

ScholarIQh-index

Haya Ascher‐Svanum has an h-index of 43 in OpenAlex.

What is the i10-index of Haya Ascher‐Svanum?

ScholarIQi10-index

Haya Ascher‐Svanum has an i10-index of 99 in OpenAlex.

What is the OpenAlex record for Haya Ascher‐Svanum?

ScholarIQopenalex

The OpenAlex for Haya Ascher‐Svanum is on the source record.

What are the most-cited papers on Haya Ascher‐Svanum?

ScholarIQmost cited works
Medication Adherence and Long-Term Functional Outcomes in the Treatment of Schizophrenia in Usual Care
Haya Ascher‐Svanum, Douglas E. Faries, Baojin Zhu, Frank R. Ernst, Marvin S. Swartz, Jeff W. Swanson
The Journal of Clinical Psychiatry. 2006489 Citations
The burden of depressive symptoms in the long-term treatment of patients with schizophrenia
R. Conley, Haya Ascher‐Svanum, Baojin Zhu, Douglas E. Faries, BJ Kinon
Schizophrenia Research. 2006296 CitationsOPEN ACCESS
The cost of relapse and the predictors of relapse in the treatment of schizophrenia
Haya Ascher‐Svanum, Baojin Zhu, Douglas E. Faries, David S. Salkever, Eric P. Slade, Xiaomei Peng, Robert R. Conley
BMC Psychiatry. 2010281 CitationsOPEN ACCESS
Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
Douglas E. Faries, Haya Ascher‐Svanum, Baojin Zhu, Christoph U. Correll, John M. Kane
BMC Psychiatry. 2005183 CitationsOPEN ACCESS
Early Response to Antipsychotic Drug Therapy as a Clinical Marker of Subsequent Response in the Treatment of Schizophrenia
Bruce J. Kinon, Lei Chen, Haya Ascher‐Svanum, Virginia L. Stauffer, Sara Kollack‐Walker, Wei Zhou, Shitij Kapur, John M. Kane
Neuropsychopharmacology. 2009180 CitationsOPEN ACCESS

Related on ScholarIQ

470M+ articles · 14-day free trial